Health News
Moms who lose a baby face higher stillbirth risk
NEW YORK (Reuters Health) - Parents who've suffered the death of an infant may have a higher-than-normal risk of stillbirth in the next pregnancy, a new study suggests.
Congress to probe listeria outbreak in cantaloupes
WASHINGTON - Lawmakers in the House of Representatives plan to investigate what caused a deadly food poisoning outbreak in cantaloupes from a Colorado farm.
Kids' daytime wetting accidents linked to ADHD
NEW YORK (Reuters Health) - Children who wet themselves are more than four times as likely as other kids to also have attention deficit/hyperactivity disorder (ADHD), according to the results of a new German study.
Sanofi says Lemtrada helps MS patients in study
PARIS - French drugmaker Sanofi said on Saturday that its experimental multiple sclerosis drug Lemtrada worked better than an older drug sold by competitor Merck KGaA at keeping patients free from relapses.
Using one embryo in IVF doesn't cut birth rate
NEW YORK (Reuters Health) - A new study from an Iowa fertility center found that implanting women with one embryo during in vitro fertilization (IVF) didn't lower their chances of having a baby, but it did mean fewer women gave birth to twins.
Mobile phones don't hike cancer risk: Danish study
LONDON - Mobile phones do not increase the risk of cancer, according to a large study involving more than 350,000 people by Danish researchers published Friday.
Pro divers are less headache-prone: study
NEW YORK (Reuters Health) - Despite concerns that water pressure and other stresses might promote headaches, professional scuba divers may actually get fewer of the painful attacks, overall, than other healthy people, say Italian researchers.
Most in Massachusetts want state push on health costs
BOSTON - Most Massachusetts residents want their state government to take action to reduce high healthcare costs that they blame on drug and insurance companies charging too much, a survey showed on Friday.
Abbott says hepatitis C combo may be a blockbuster
NEW YORK - Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 billion.
Federal ban on chemicals in street drug called bath salts
WASHINGTON - Federal authorities on Friday issued a temporary ban on chemicals used in a new type of street drug known as bath salts, which is increasingly popular among teens.
- Soyuz rocket places satellites into orbit
|
- Back space taxis or pay more for Russian rides: NASA
- Japanese team wins Australian solar car race
|
- Europe's oldest nuclear reactor to close early
- Space taxi delays spur Bigelow Aerospace layoffs
- Mosquito lab handles "world's most dangerous animals"
- Russians see room for moonbase in lunar lava caves
- More Facebook friends linked to bigger brain areas
- Malaria scientist celebrates success after 24 years
- Analysis: ViaSat's growth hinges on satellite launch
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
